Use of 5% sulfamylon (mafenide) solution after excision and grafting of burns.
In previous reports, 5% sulfamylon solution has been utilized on unexcised burns and granulation tissue. We prospectively evaluated 67 burn patients to determine graft take and the incidence of side effects with use of sulfamylon solution dressings after excision and grafting. Of patients excised and grafted, the mean graft take for a total of 100 procedures was 86%. Rash occurred in 18% of patients and sulfamylon was discontinued with no sequelae. Twenty-five percent had at least one positive fungal wound culture, yet only 3% required treatment for candidemia. Those patients who developed a rash and fungal colonization had a significantly larger percent burn and were treated with sulfamylon for a longer period of time. Pain intensity was rated on a Visual Analog Scale with a mean score of 2.4; in no case was the pain considered severe enough by the patient to terminate treatment. Acidosis was present in 3% of patients but felt to be unrelated to the sulfamylon treatment. As an antimicrobial agent, 5% sulfamylon solution is a viable alternative for fresh autografts with excellent graft take and acceptable side effects.
Lee
J J
JJ
University of Washington Burn Center, Seattle.
Marvin
J A
JA
Heimbach
D M
DM
Grube
B J
BJ
D000287:Administration, Topical; D000328:Adult; D001458:Bandages; D002056:Burns / Q000601:surgery*; D005260:Female; D006801:Humans; D008272:Mafenide / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D010147:Pain Measurement; D011446:Prospective Studies; D016038:Skin Transplantation; D012996:Solutions; D013449:Sulfonamides / Q000627:therapeutic use*; D014946:Wound Infection / Q000517:prevention & control*
D012996:Solutions; D013449:Sulfonamides; D008272:Mafenide